Brought to you by 
BTG pays $180mm up front, $40mm in earn-outs for clot-dissolving device firm Ekos
24 Aug 2020
Executive Summary
BTG International Inc.--the North American headquarters for BTG PLC, which markets specialty pharmaceuticals and interventional devices--is paying $180mm up front for privately held Ekos Corp. (thrombolysis devices). Ekos is also entitled to $40mm in earn-outs tied to reaching revenue goals in 2013 ($20mm) and 2014-2015 ($20mm).
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Drug Delivery
- Site Specific
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BTG pays $180mm up front, $40mm in earn-outs for clot-dissolving device firm Ekos
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice